@Sturgis,
batimastat - A non-cytotoxic inhibitor of matrix metalloproteinase, which inhibits matrix digestion, cell migration and smooth muscle cell migration without interfering with re-endothelialisation. It was first formulated as an anti-cancer drug and later studied for preventing in-stent restenosis, as it selectively targets migrating cells.
